Skip to main content
. Author manuscript; available in PMC: 2015 Nov 13.
Published in final edited form as: Cell. 2015 Aug 13;162(4):727–737. doi: 10.1016/j.cell.2015.07.019

Figure 5. P53 suppresses and AID promotes Plasmodium induced lymphoma.

Figure 5

A- Survival of Plasmodium infected mice. All mice are also CD19cre/+.

B- Spleen histology of Plasmodium infected CD19cre/+p53lox/lox mice. L4 is AID proficient lymphoma and S2 is AID deficient benign B cell hyperplasia with marked extramedullary hematopoiesis.

C- Lymphoma versus benign hyperplasia in Plasmodium infected mice. Lymphoid tissues were evaluated by histology, immunohistochemistry, and flow cytometry. “Benign hyperplasia” indicates mice with splenomegaly but normal B cell distribution, with B220+ cells confined to follicular areas. “Atypical hyperplasia or early neoplasia” denotes splenomegaly and B220+ cells expanding into the periarteriolar lymphoid sheats (PALS). “Lymphoma” defines abnormal lymphoid tissue architecture and/or dissemination to multiple organs.

D- Extramedullary hematopoiesis in Plasmodium infected mice. Spleen sections were evaluated for the degree of extramedullary hematopoiesis.

See also Figure S5 and Table S2.